Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 23769226)

1.

Tamoxifen therapy for patients with breast cancer.

Neven P, Joensuu H, Osborne K, Cardoso F, Loibl S, Linn S, Goldhirsch A, Ortmann O, Senn HJ, Hayes DF.

Lancet. 2013 Jun 15;381(9883):2078. doi: 10.1016/S0140-6736(13)61237-4. No abstract available. Erratum in: Lancet. 2013 Jun 22;381(9884):2166. Joenssu, Heikki [corrected to Joensuu, Heikki].

PMID:
23769226
2.

Tamoxifen therapy for patients with breast cancer.

Litton J, Buzdar A, Mac Gregor MC, Gonzalez-Angulo A, Hortobagyi G.

Lancet. 2013 Jun 15;381(9883):2077-8. doi: 10.1016/S0140-6736(13)61236-2. No abstract available.

PMID:
23769223
3.

Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer.

Machin D, Andersen KW.

J Natl Cancer Inst. 1997 May 7;89(9):659-60. No abstract available.

4.

[Endocrine therapy for advanced breast cancer].

Yoshinami T, Yagi T, Ishitobi M.

Nihon Rinsho. 2012 Sep;70 Suppl 7:641-4. Japanese. No abstract available.

PMID:
23350477
5.

Tamoxifen therapy for patients with breast cancer.

Huiart L, Ferdynus C, Giorgi R.

Lancet. 2013 Jun 15;381(9883):2077. doi: 10.1016/S0140-6736(13)61235-0. No abstract available.

PMID:
23769224
6.

Duration of adjuvant tamoxifen therapy.

Bryant J, Fisher B, Dignam J.

J Natl Cancer Inst Monogr. 2001;(30):56-61.

PMID:
11773293
7.

Overview of randomized trials of systemic adjuvant therapy.

Ravdin PM.

Cancer Treat Res. 2000;103:157-81. Review. No abstract available.

PMID:
10948446
8.

Caring for the breast cancer survivor.

Abdel-Razeq H.

Am J Med. 2011 Feb;124(2):e11; author reply e13. doi: 10.1016/j.amjmed.2010.08.016. No abstract available.

PMID:
21295181
9.

Tamoxifen in early breast cancer.

Arriagada R.

Lancet. 1998 Aug 1;352(9125):403-4. No abstract available.

PMID:
9717953
10.

Can endocrine treatment for hormone-positive premenopausal women with early breast cancer replace adjuvant chemotherapy?

Malayeri R.

J Clin Oncol. 2003 Jun 15;21(12):2444-5; author reply 2446-7. No abstract available.

PMID:
12805348
11.

Delayed adjuvant tamoxifen in postmenopausal women with axillary node-negative breast cancer: mortality over 10 years.

Love RR, Olsen MR, Havighurst TC.

J Natl Cancer Inst. 1999 Jul 7;91(13):1167-8. No abstract available.

13.

The optimal duration of adjuvant hormonal therapy for early-stage breast cancer.

Winer E.

Clin Adv Hematol Oncol. 2008 Aug;6(8):573-4. Review. No abstract available.

PMID:
18820598
14.
15.

[The effectiveness of adjuvant systemic therapy in organ-preserving therapy of breast cancer].

Semiglazov VF, Kanaev SV, Bugrova IL, Chagunava OL.

Vopr Onkol. 1998;44(4):408-13. Russian.

PMID:
9807203
16.

Paradigm shift in adjuvant treatment of receptor positive premenopausal breast cancer patients? Not yet!

Samur M, Bozcuk HS.

J Clin Oncol. 2003 Jun 15;21(12):2444; author reply 2445-7. No abstract available.

PMID:
12805349
17.

Combined endocrine blockade in premenopausal breast cancer: a superior therapeutic option for adjuvant management?

Kohli M, Khan MA, Mehta P, Hutchins L.

J Clin Oncol. 2003 Jun 15;21(12):2445. No abstract available.

PMID:
12805351
18.

Pharmacokinetics of tamoxifen in premenopausal and postmenopausal women with breast cancer.

Lien EA, Anker G, Ueland PM.

J Steroid Biochem Mol Biol. 1995 Nov;55(2):229-31.

PMID:
7495702
19.

Tamoxifen: the long and short of it.

Swain SM.

J Natl Cancer Inst. 1996 Nov 6;88(21):1510-2. No abstract available.

PMID:
8901846
20.

[Tamoxifen; wider indications, more frequent controls?].

Rutgers EJ, Nortier JW, Beex I; Nationaal Borstkankeroverleg Nederland.

Ned Tijdschr Geneeskd. 2001 Sep 8;145(36):1766-7. Dutch. No abstract available.

PMID:
11589197
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk